The Lupus Foundation of America (LFA) was awarded a one-year, $1 million grant from the Office of Minority Health at the…
Articles by Ines Martins, PhD
The Lupus Agencies of New York State (LANYS) announced two advocacy triumphs this legislative session — passage of the Lupus…
Dutch biopharmaceutical company Argenx recently reported initial data from its Phase 1 multiple ascending dose clinical trial of ARGX-113 in…
Aurinia Pharmaceuticals recently released an analysis of the first seven patients to complete 24 weeks in its open-label, exploratory…
Ann Marshak-Rothstein, professor of Medicine and Rheumatology at University of Massachusetts Memorial Medical School, received the 2016 Lupus Insight Prize…
A bill recently moved forward by the U.S. Senate Appropriations Committee on labor, health human services and education for 2017…
Regen BioPharma has identified small molecules that activate NR2F6, an immune checkpoint recently identified by the company. This is the…
A bill recently passed by the U.S. Senate Appropriations Committee includes critical funding for lupus research and education. The Lupus Foundation…
Researchers at New York University School of Medicine discovered that an enzyme’s failure to digest the DNA from dying cells can trigger the production…
Mallinckrodt PLC presented the first results from its two-part pilot study’s 44-week open label extension period, on the efficacy of…